Schedule Your Consultation In research and emerging use, AOD-9604 is associated with: These are research-stage findings, not guarantees, and results vary
Patients with mild to moderate renal impairment generally do not require dose adjustment, but closer monitoring may be warranted, particularly for signs of gastrointestinal adverse effects that could lead to dehydration and worsening renal function
Local tissue reaction may occur at the site of injection in cattle, but will be transient and disappear in less than one month
For horses and cattle, the intramuscular injection dosage is 10-20ml per dose
primary care-based study In a large nationally representative sample of U.S
[1] [2] [3] [20] In order to prevent mitochondrial malfunction and sustain metabolic function/energy generation (ATP), NAD+ supplementation may counterbalance the age-related degradation of NAD+ and its precursor nicotinamide mononucleotide by NADases, particularly CD38
